TABLE 1.
Baseline characteristics of patients enrolled in the study
| Patient | Age | Race | Weight | BSA | Chemotherapy |
|---|---|---|---|---|---|
| years | kg | ||||
| 1 | 63 | C | 54 | 1.63 | PLD |
| 2 | 51 | C | 73 | 1.9 | PLD |
| 3 | 57 | C | 71 | 1.78 | PLD |
| 4 | 67 | C | 89 | 1.96 | PLD + carboplatin |
| 5 | 76 | C | 91 | 1.91 | PLD |
| 6 | 51 | C | 72 | 1.84 | PLD + carboplatin |
| 7 | 53 | C | 94 | 1.94 | PLD + carboplatin |
| 8 | 75 | C | 48 | 1.46 | PLD |
| 9 | 44 | C | 77 | 1.91 | PLD + carboplatin |
| 10 | 52 | AA | 116 | 2 | PLD |
| Mean ± S.D. or Total | 59 ± 10.9 | 9 C, 1AA | 78 ± 20 | 1.8 ± 0.2 | 6 PLD alone 4 PLD + carboplatin |
AA, African American; BSA, body surface area; C, Caucasian.